Optomagic, Korean Research Institute of Bioscience and Biotechnology deal

Optomagic’s Chemizon Inc. drug discovery services division and the institute will form a new company to commercialize the institute’s IP, initially focusing on cancer, CNS and infectious diseases. Che...